European Archives - Page 15 of 1104 - European Medical Journal

Multifaceted Anaemia Treatment Improves Recovery in Critically Ill Individuals

A recent trial shows that a multifaceted anaemia treatment bundle improves haemoglobin recovery in critically ill patients, enhancing recovery after surgery or critical illness.

Roux-en-Y Gastric Bypass: The Best Choice for Severe Obesity Treatment?

Roux-en-Y gastric bypass outperforms sleeve gastrectomy and adjustable gastric banding, study finds.

Flu Vaccine Trials Show Safety and Immune Response

The revised mRNA-1010 formulation, evaluated in a subsequent trial, met all primary immunogenicity goals.

EBMT 2025 Interview: Magdalena Corona de Lapuerta

In this interview, Magdalena Corona de Lapuerta, recipient of the Jian-Jian Luan Award for Lymphoma Transplant Research, discussed her…

Intravenous Anti-CGRP Therapy for the Treatment of Migraine

This promotional advertorial article has been fully commissioned by Lundbeck Ltd. UK PI & AER info is available within the article…

Revised Guidelines Highlight Wilson’s Disease Diagnostic Advances

While effective therapies exist, challenges remain in managing acute liver failure, where transplantation may be life-saving.

Provisional Stenting Outcomes: Does Final Kissing Balloon Dilatation Make a Difference?

Final kissing balloon dilatation reduces lesion-specific complications but shows no impact on broader cardiac outcomes in stenting procedures.

Social Isolation Worsens Osteoarthritis Risk in Patients With Asthma

Asthma may raise the risk of developing osteoarthritis, with socially isolated or lonely individuals facing even greater susceptibility, according to a new large-scale cohort study.

Menopausal Symptoms May Predict Later-Life Cognitive Decline

New research links the severity of menopausal symptoms to cognitive decline and mild behavioural impairment in later life, with hormone therapy showing potential protective effects.

Racial Disparities in Immunotherapy Use for Triple-Negative Breast Cancer

A study reveals racial disparities in immunotherapy use for triple-negative breast cancer, with Black patients less likely to receive treatment.